Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Regulatory News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Redx Pharma Plc Shares now trading on JP Jenkins

1 May 2024 07:04

JP Jenkins Ltd Redx Pharma Plc Shares now trading on JP Jenkins 01-May-2024 / 07:03 GMT/BST The issuer is solely responsible for the content of this announcement.


1st May 2024

JPJ: REDX

ISIN: GB00BSNB6S51

Redx Pharma Plc

 

Shares now trading on JP Jenkins

 

 

Alderley Park, 1st May 2024 - Shares in Redx Pharma Plc (“Redx”) (https://www.redxpharma.com/) have been admitted to trade on JP Jenkins share dealing platform. Redx is based at Block 33 Mereside, Alderley Park, Macclesfield, England, SK10 4TG and is registered as a company in England and Wales under Companies House, company number 07368089.

 

Redx (JPJ: REDX) is a clinical-stage biotechnology company focused on the discovery and development of novel, small molecule, targeted therapeutics for the treatment of fibrotic disease and cancer.

 

JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).

 

Shareholders wishing to trade these securities can do so through their stockbroker. Trades will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer. Trades can be conducted, and limits can be accepted, during normal business hours. Shareholders or potential investors can place limits via their existing UK regulated stockbroker.

 

The indicative pricing for the ordinary shares (ISIN: GB00BSNB6S51), as well as the transaction history, will be available on the JP Jenkins website at (https://jpjenkins.com/)

 

Peter Collum, Chief Financial Officer, Redx Pharma said “We are pleased to be able to offer our shareholders the ability to continue trading Redx shares on the JP Jenkins platform as a private company following the delisting from AIM. The JP Jenkins platform allows buying and selling of shares through a structured secondary market using brokers in the same manner as trading a listed security. This will allow us to focus on the execution of our corporate strategy, driving forward our pipeline of differentiated, novel drug candidates and ultimately delivering shareholder returns.

 

Veronika Oswald, Commercial Director of JP Jenkins said: “Red’s move from AIM to the JP Jenkins venue represents a significant step forward in our journey towards accessibility and liquidity for their investors. This transition underscores our commitment to fostering a dynamic and thriving investment environment. We're thrilled to embark on this new chapter with Redx, confident in the opportunities it will unlock for both companies."

 

For further information, please contact:

 

 

JP Jenkins Limited

Redx Pharma Plc

Contact: Veronika Oswald (Director)

Caitlin Pearson (Head of Communications)

+44 (0)20 7469 0937

01625 469 918

IR@redxpharma.com

 

 

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1893571 01-May-2024 

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
26th Mar 202011:45 amRNSForm 8.5 (EPT/RI)
25th Mar 202011:45 amRNSHolding(s) in Company
25th Mar 202011:45 amRNSForm 8.5 (EPT/RI)
24th Mar 20206:13 pmRNSForm 8.3 - RedX Pharma PLC
24th Mar 202011:33 amRNSForm 8.5 - RedX Pharma Plc
24th Mar 20208:55 amRNSForm 8 (DD)
23rd Mar 20201:19 pmRNSHolding(s) in Company
23rd Mar 202012:37 pmRNSForm 8.5 - Redx Pharma Plc
23rd Mar 202011:45 amRNSForm 8.5 (EPT/RI)
23rd Mar 202010:42 amRNSForm 8 (DD) - Redx Pharma PLC
20th Mar 20204:37 pmRNSForm 8.3 - Redx Pharma plc
20th Mar 20204:30 pmRNSForm 8.3 - Redx Pharma
20th Mar 20201:55 pmRNSHolding(s) in Company
19th Mar 202011:45 amRNSForm 8.5 (EPT/RI)
18th Mar 20202:01 pmRNSForm 8.3 - Redx Pharma PLC
17th Mar 20202:54 pmRNSForm 8.3 - Seneca Partners Limited
17th Mar 20202:30 pmRNSForm 8 (OPD) Redx Pharma plc
17th Mar 20202:23 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: Redx Pharma PLC
17th Mar 20202:14 pmRNSForm 8.3 - RedX Pharma plc
17th Mar 202011:45 amRNSForm 8.5 (EPT/RI)
16th Mar 20205:31 pmRNSHolding(s) in Company
16th Mar 20205:30 pmRNSHolding(s) in Company
16th Mar 20202:47 pmRNSForm 8.3 - Redx Pharma plc
16th Mar 202011:45 amRNSForm 8.5 (EPT/RI)
16th Mar 20209:53 amRNSForm 8.3 - [REDX PHARMA PLC]
13th Mar 20207:37 amRNSHoldings in Company
13th Mar 20207:12 amRNSRECOMMENDED MANDATORY OFFER FOR REDX PHARMA PLC
13th Mar 20207:00 amRNSConfirmation of Private Approach
11th Mar 20207:00 amRNSFinal Results for Year Ended 30 September 2019
9th Mar 202010:05 amRNSHolding(s) in Company
2nd Mar 202011:45 amRNSForm 8.5 (EPT/RI)
2nd Mar 20207:00 amRNSRe-release: Funding Update
28th Feb 20206:29 pmRNSFunding update
28th Feb 20205:56 pmRNSTermination of discussions with Yesod Bio-Sciences
28th Feb 20204:57 pmRNSRule 2.8 Announcement
27th Feb 202011:45 amRNSForm 8.5 (EPT/RI)
26th Feb 202011:45 amRNSForm 8.5 (EPT/RI)
25th Feb 202011:45 amRNSForm 8.5 (EPT/RI)
24th Feb 202011:45 amRNSForm 8.5 (EPT/RI)
20th Feb 202011:45 amRNSForm 8.5 (EPT/RI)
19th Feb 202011:45 amRNSForm 8.5 (EPT/RI)
18th Feb 202011:45 amRNSForm 8.5 (EPT/RI)
17th Feb 202011:45 amRNSForm 8.5 (EPT/RI)
14th Feb 20204:16 pmRNSFurther statement re Rule 2.6 Extension
14th Feb 202011:45 amRNSForm 8.5 (EPT/RI)
13th Feb 202011:45 amRNSForm 8.5 (EPT/RI)
12th Feb 202011:45 amRNSForm 8.5 (EPT/RI)
11th Feb 202011:45 amRNSForm 8.5 (EPT/RI)
10th Feb 202011:45 amRNSForm 8.5 (EPT/RI)
7th Feb 202011:45 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.